SFA
CGEN icon

Semmax Financial Advisors’s Compugen CGEN Stock Holding History

Semmax Financial Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,339
Closed -$22K – 355
2019
Q1 		$22K Buy
+5,339
New +$18.3K 0.02% 254

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Semmax Financial Advisors's CGEN Position: Q2 2019 in Review

Semmax Financial Advisors sold out of Compugen (CGEN) in Q2 2019, closing a stake of 5,339 shares — an estimated $22K sold.

Semmax Financial Advisors first reported a position in CGEN in Q1 2019 and held it in 1 quarter. The position peaked at $22K in Q1 2019. 41 funds tracked by Wall St. Rank hold CGEN as of Q2 2019.

  • Semmax Financial Advisors reported no remaining Compugen position as of Q2 2019 after selling out during the quarter.
  • Semmax Financial Advisors sold 5,339 Compugen shares in Q2 2019, an estimated $22K.
  • Semmax Financial Advisors first reported a position in Compugen in Q1 2019 and held it in 1 quarter.
  • Semmax Financial Advisors's Compugen position peaked at $22K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held Compugen as of Q2 2019.

Based on Semmax Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.